Article

Utility of circulating tumor DNA for detection and monitoring of endometrial cancer recurrence and progression

2020-03-06

Abstract excerpt

<h4>ABSTRACT</h4> Despite the increasing incidence of endometrial cancer (EC) worldwide and the poor overall survival of patients who recur, no reliable biomarker exists for detecting and monitoring EC recurrence and progression during routine follow-up. Circulating tumor DNA (ctDNA) is a sensitive method for monitoring cancer activity and stratifying patients that are likely to respond to therapy. As a pilot stu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: da12bce0-df2e-5bb3-af1a-33c1102af1d4
DOI: 10.1101/2020.03.04.20030908

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Utility of circulating tumor DNA for detection and monitoring of endometrial cancer recurrence and progressionDOI 10.1101/2020.03.04.20030908Read

Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and ProgressionSemantic proximity Read

Circulating tumor DNA as a prognostic marker in high-risk endometrial cancerSemantic proximity Read

Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer.Semantic proximity Read

Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study.Semantic proximity Read

ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATIONSemantic proximity Read

Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas.Semantic proximity Read

Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patientsSemantic proximity Read

High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer.Semantic proximity Read

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.Semantic proximity Read

Mutational profile in circulating tumor DNA in a patient affected by low-risk endometrial cancer: predictable tool of relapse?Semantic proximity Read

Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic Malignancies.Semantic proximity Read

Genomic Profiling in Patients with Endometrial Cancer by Deep Sequencing of Vaginal Swabs and PlasmaSemantic proximity Read